Welcome at the Institute of Clinical Neuroimmunology

Prof. Hohlfeld

Prof. Dr. Hohlfeld

Our institute is devoted to the diagnosis and treatment of neuroimmunological diseases, that is, autoimmune disorders of the nervous system. In autoimmune diseases, the immune system “erroneously” attacks the body´s own tissues. By far the most frequent of these diseases is multiple sclerosis.

The Institute of Clinical Neuroimmunology was founded in 1999. It is the first university institute in Germany focusing on neuroimmunological diseases. [Continue]



Kerschensteiner_Startseite

Prof. Dr. Kerschensteiner


 

Prize for the best PhD thesis of the Medical University Vienna in 2016 for Elisabeth Schuh

06.02.2017 - The prizes for the best PhD thesis and habilitations of the Medical University Vienna in 2016 were awarded during the university lecture of the vfwf. Eligible candidates were able to submit their thesis, which were completed at the Medical University Vienna in 2016. Due to the numerous high-quality submissions, the vfwf decided to award four winners. The prizes were handed over at the university lecture of the vfwf in the auditorium center of the MedUni Vienna. [more...]

 
Presseerklärung

DMSG Forschungsprojekte zur Progredienten Multiplen Sklerose

04.12.2016 - Dr. Mehrnoosh Jafari und Prof. Martin Kerschensteiner wollen verstehen, wie es bei der Progredienten Verlaufsform der Multiplen Sklerose zum Nervenzellschaden kommt. Dieses Forschungsvorhaben wird jetzt von der Deutschen Multiple Sklerose Gesellschaft gefördert. [more...]

 
Dtsch Arztebl Int 2016; 113(51-52): 879-86; DOI: 10.3238/arztebl.2016.0879

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis

03.12.2016 - The growing number of drugs used to treat MS demands great efforts to minimize the potential risks. To this end, interdisciplinary risk management plans are essential. Here we describe the type and extent of risks, the measures needed for prevention/early detection, and provide practical advice f... [more...]

 

Auf der Suche nach neuen Wegen zur Neuroprotektion

01.01.2016 - Klinische Studien mit unerwartetem Ausgang können die Basis für neue Erkenntnisse sein. Obwohl die Depletion von B-Lymphozyten vielversprechend bei der Multiplen Sklerose (MS) ist, führte das Block... [more...]

Engagement für Multiple Sklerose - AMSEL-Stiftungs-Preise 2016 verliehen [Deutsch]

13.10.2016 - Mit Thekla Groll, Sabine Marina und Prof. Dr. Reinhard Hohlfeld zeichnete die AMSEL-Stiftung drei besonders engagierte Menschen aus. Über 200 Gäste kamen zur Feier ins Porsche-Museum. [more...]

Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model.

02.12.2016 - Here we investigate how oligodendrocyte damage is initiated in multiple sclerosis (MS) and EAE. We can show that oligodendrocyte damage spreads centripetally and that the formation of focal myelin ... [more...]